Market Intelligence

Carl Zeiss Meditec ups FY core profit guidance, shares soar

BERLIN, April 12 (Reuters) - German medical technology company Carl Zeiss Meditec raised its full-year core profit outlook on Friday, sending shares higher.

The margin for earnings before interest and taxes (EBIT) is now expected to reach 15 to 17.5 percent, up from a previous guidance of 14 to 16 percent.

Shares in the company, which were included in Germany's midcap MDAX index in December, were up 6.2 percent at 0822 GMT.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Stocks Earnings

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More